BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17002642)

  • 1. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
    Jenkins PV; O'Donnell JS
    Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease.
    Millar CM; Brown SA
    Blood Rev; 2006 Mar; 20(2):83-92. PubMed ID: 16507387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting at the variable expressivity of von Willebrand disease.
    Levy G; Ginsburg D
    Thromb Haemost; 2001 Jul; 86(1):144-8. PubMed ID: 11487001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of type 1 von Willebrand disease.
    Goodeve A
    Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor and thrombosis.
    Franchini M; Lippi G
    Ann Hematol; 2006 Jul; 85(7):415-23. PubMed ID: 16568319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of plasma concentration of von Willebrand factor.
    Orstavik KH
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):527-31. PubMed ID: 1714855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.
    Brown SA; Collins PW; Bowen DJ
    Thromb Haemost; 2002 Jun; 87(6):990-6. PubMed ID: 12083507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
    Ward SE; O'Sullivan JM; O'Donnell JS
    Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ABO blood group on von Willebrand response to exercise.
    Ribeiro JL; Salton GD; Bandinelli E; Oliveira AR; Roisenberg I
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):454-8. PubMed ID: 18160595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.
    O'Donnell J; Laffan MA
    Transfus Med; 2001 Aug; 11(4):343-51. PubMed ID: 11532189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.
    O'Donnell J; Boulton FE; Manning RA; Laffan MA
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):335-41. PubMed ID: 11834538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor.
    Haley E; Babar N; Ritter C; Downes KA; Green D; Shurin S; Sarode R
    Am J Hematol; 2002 Nov; 71(3):229-31. PubMed ID: 12410584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions.
    Daidone V; Cattini MG; Pontara E; Sartorello F; Gallinaro L; Marotti A; Scaroni C; Pagnan A; Casonato A
    Thromb Haemost; 2009 Feb; 101(2):298-304. PubMed ID: 19190813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
    Franchini M; Favaloro EJ; Targher G; Lippi G
    Crit Rev Clin Lab Sci; 2012; 49(4):137-49. PubMed ID: 22856614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.